Marc Samuels and Lindsay Bealor Greenleaf quoted in BioPharma Dive
ADVI CEO Marc Samuels and Director Lindsay Bealor Greenleaf are quoted in BioPharma Dive’s look at why drug pricing seems so complicated. Both outline a roadmap for successful pricing strategy.
Marc Samuels and Director Lindsay Bealor Greenleaf are quoted in BioPharma Dive
Written By Judy Packer-Tursman
Monday, 27 February 2017
ADVI CEO Marc Samuels and Director Lindsay Bealor Greenleaf are quoted in BioPharma Dive’s look at why drug pricing seems so complicated. Both outline a roadmap for successful pricing strategy.
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.